Showing results (361-370 of 436) with videos related to
Sort By:
Pageof 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 10, 2008
Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapyFred R Hirsch, Roy S Herbst, Christine Olsen, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 7, 2005
Increased epidermal growth factor receptor gene copy number detected by fluorescence in situ hybridization associates with increased sensitivity to gefitinib in patients with bronchioloalveolar carcinoma subtypes: a Southwest Oncology Group StudyFred R Hirsch, Marileila Varella-Garcia, Jason McCoy, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 22, 2014
Ex vivo-expanded natural killer cells demonstrate robust proliferation in vivo in high-risk relapsed multiple myeloma patientsSusann Szmania, Natalia Lapteva, Tarun Garg, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 7, 2006
Frequency, characteristics, and reversibility of peripheral neuropathy during treatment of advanced multiple myeloma with bortezomibPaul G Richardson, Hannah Briemberg, Sundar Jagannath, et al.JCI Insight|April 20, 2018
Antigen-mediated regulation in monoclonal gammopathies and myelomaShiny Nair, Joel Sng, Chandra Sekhar Boddupalli, et al.The Journal of Clinical Investigation|July 26, 2022
CST6 suppresses osteolytic bone disease in multiple myeloma by blocking osteoclast differentiationDongzheng Gai, Jin-Ran Chen, James P Stewart, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung CancerWilliam D Travis, Dorothy J Giroux, Kari Chansky, et al.Biorxiv : the Preprint Server for Biology|July 7, 2021
Qualification of ELISA and neutralization methodologies to measure SARS-CoV-2 humoral immunity using human clinical samplesSasha E Larsen, Bryan J Berube, Tiffany Pecor, et al.Blood|April 23, 2017
Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myelomaLeo Rasche, Edgardo Angtuaco, James E McDonald, et al.The New England Journal of Medicine|June 27, 2003
A phase 2 study of bortezomib in relapsed, refractory myelomaPaul G Richardson, Bart Barlogie, James Berenson, et al.Pageof 44